Essays about: "generic drugs"
Showing result 16 - 20 of 21 essays containing the words generic drugs.
-
16. Abuse of a Dominant Position by Pharmaceutical Undertakings in EC Law
University essay from Lunds universitet/Juridiska institutionenAbstract : In June 2005 the Commission imposed a &euro&semic60 million fine on AstraZeneca for abusing its dominant position. This was followed in December 2005 by the Discussion Paper on the application of Article 82 EC, issued by the Directorate-General for Competition of the European Commission. READ MORE
-
17. Compulsory Licensing of Pharmaceutical Products & Access to Essential Medicines in Developing Countries
University essay from Ekonomiska institutionenAbstract : For many years pharmaceutical patents and their impact on prices have been at the centre of the international debate over insufficient access to lifesaving HIV/AIDS medicines in developing countries. The conflict has largely revolved around the implementation of an intellectual property system in the developing world, subsequent the adaptation of the TRIPS Agreement, which has made a 20 year pharmaceutical patent protection mandatory for these countries and consequently contributed to high drug prices for patented medicines as well as limited the use of generic drugs. READ MORE
-
18. Pharmaceutical Innovation Versus Generic Competition - In the Context of the New EU Pharmaceutical Legislation
University essay from Lunds universitet/Juridiska institutionenAbstract : Development of innovative drugs is a lengthy, risky and expensive enterprise, and the research-based pharmaceutical industry depends uniquely on intellectual property rights, e.g. patents and regulatory data protection to support its investments in drug development activities. READ MORE
-
19. Are affordable pharmaceuticals within reach for developing countries - Clarifying the access situation of today and projecting beyond the Paragraph 6-Agreement
University essay from Lunds universitet/Juridiska institutionenAbstract : The increasing spread of global pandemics such as HIV/AIDS, tuberculosis (TB) and malaria, in particular in developing countries, has forced the engagement of industrialized countries and pharmaceutical companies. Because medicines to cure these diseases are often under patent protection, they are not affordable for people in developing countries where health crises prevail. READ MORE
-
20. Are legislators able to meet efficiency goals? : an analysis of the pharmaceutical industry
University essay from Ekonomiska institutionenAbstract : During the last decades, legislators have tried to meet the goal of increased R&D in the pharmaceutical industry through an extension of the patent length. In parallel, an attempt to minimise ex post social costs has been made through the introduction of a shortened drug approval process for generic drugs as well as a so-called Bolar provision, giving generic producers earlier access to patented information. READ MORE
